# HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

> **NCT00480805** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 312 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Hypertension

## Interventions

- **DRUG:** MK0954A, losartan potassium (+) hydrochlorothiazide (HYZAAR) / Duration of Treatment : 8 Weeks
- **DRUG:** Comparator : ramipril /Duration of Treatment : 8 Weeks

## Key facts

- **NCT ID:** NCT00480805
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08-08
- **Primary completion:** 2002-10-15
- **Final completion:** 2002-10-16
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00480805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00480805, "HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00480805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*